Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Qi, Minga; * | Liu, Dongmeib | Zhang, Shuhonga
Affiliations: [a] Department of Digestive System, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, Shandong, China | [b] Transfusion Centre, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, Shandong, China
Correspondence: [*] Corresponding author: Ming Qi, Department of Digestive System, Jinan Central Hospital Affiliated to Shandong University, Jiefang Road No.105, Jinan 250013, Shandong, China. Tel.: +86 0531 68746224; Fax: +86 0531 68746224; E-mail:[email protected]
Abstract: BACKGROUND: Multidrug resistance in gastric cancer greatly impedes the efficacy of chemotherapy. OBJECTIVE: To explore the efficacy of microRNA-21 (mir-21) in distinguishing metastatic gastric cancer (MGC) with chemoresistance. METHODS: From April 2012 to May 2015, 92 MGC patients were enrolled. Cisplatin and fluorouracil-based systemic chemotherapy was given, and patients' characteristics and follow-up data were collected. In addition, miR-21 expression was determined in tumor tissue and plasma. RESULTS: Sixty-seven patients responded to chemotherapy, and chemotherapy resistance was observed in 25 patients. miR-21 expression in tumor tissue and plasma was significantly elevated in the chemotherapy-resistant group (CRG) compared to the chemotherapy-sensitive group (CSG) (p< 0.001). miR-21 expression in tissue was associated with tumor differentiation (p= 0.042), and plasma miR-21 was correlated with gender (p= 0.016), tumor differentiation (p= 0.003), and number of metastatic sites (p< 0.001). Receiver operating characteristic (ROC) analysis indicated that miR-21 in tissue yielded an area under the ROC curve (AUC) of 0.830 (95%CI: 0.737-0.900, sensitivity: 88.0%, specificity: 68.7%) in distinguishing CRG from CSG; and plasma miR-21 yielded an AUC of 0.759 (95%CI: 0.658-0.842, sensitivity: 52.0%, specificity: 88.1%) in distinguishing CRG form CSG. Log-rank test and Cox proportional hazard regression analysis indicated that patients with higher miR-21 expression in tissue and plasma experienced shorter overall survival (P< 0.001). CONCLUSION: miR-21 could serve as a potential biomarker to identify MGC with chemoresistance.
Keywords: microRNA-21, gastric cancer, biomarker, survival analysis
DOI: 10.3233/CBM-161732
Journal: Cancer Biomarkers, vol. 18, no. 4, pp. 451-458, 2017
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]